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We have recently purified a rat brain membrane-
bound nonlysosomal ceramidase (El Bawab, S., Bielaw-
ska, A., and Y. A. Hannun (1999) J. Biol. Chem. 274,
27948–27955). Using peptide sequences obtained from
the purified rat brain enzyme, we report here the clon-
ing of the human isoform. The deduced amino acid se-
quence of the protein did not show any similarity with
proteins of known function but was homologous to three
putative proteins from Arabidospis thaliana, Mycobac-
terium tuberculosis, and Dictyostelium discoideum. Sev-
eral blocks of amino acids were highly conserved in all
of these proteins. Analysis of the protein sequence re-
vealed the presence at the N terminus of a signal peptide
followed by a putative myristoylation site and a putative
mitochondrial targeting sequence. The predicted molec-
ular mass was 84 kDa, and the isoelectric point was 6.69,
in agreement with rat brain purified enzyme. Northern
blot analysis of multiple human tissues showed the pres-
ence of a major band corresponding to a size of 3.5
kilobase. Analysis of this major band on the blot indi-
cated that the enzyme is ubiquitously expressed with
higher levels in kidney, skeletal muscle, and heart. The
enzyme was then overexpressed in HEK 293 and MCF7
cells using the pcDNA3.1/His-ceramidase construct, and
ceramidase activity (at pH 9.5) increased by 50- and
12-fold, respectively. Next, the enzyme was character-
ized using lysate of overexpressing cells. The results
confirmed that the enzyme catalyzes the hydrolysis of
ceramide in the neutral alkaline range and is independ-
ent of cations. Finally, a green fluorescent protein-cer-
amidase fusion protein was constructed to investigate
the localization of this enzyme. The results showed that
the green fluorescent protein-ceramidase fusion protein
presented a mitochondrial localization pattern and colo-
calized with mitochondrial specific probes. These results
demonstrate that this novel ceramidase is a mitochon-
drial enzyme, and they suggest the existence of a topolog-
ically restricted pathways of sphingolipid metabolism.
The lipid mediator ceramide has been suggested to play a
critical role in cell growth, differentiation, and apoptosis (1, 2).
Several mechanisms are involved in the regulation of cellular
ceramide levels, which include activation of sphingomyeli-
nases, activation of the de novo synthetic pathway, and inhibi-
tion of ceramidases (CDase).1 Ceramidases hydrolyze ceramide
to form sphingosine, which in turn can serve as a substrate for
sphingosine kinase, resulting in the formation of sphingosine-
1-phosphate. Ample evidence suggests distinct functions for
these sphingolipids (1).
Recent studies are also beginning to suggest a role for cer-
amidases in regulating the net levels of ceramide in response to
stimuli. For example, it has been shown in rat hepatocytes that
interleukin 1b at low concentration activates sphingomyeli-
nases and ceramidases, resulting in the formation of sphingo-
sine, whereas high concentrations of interleukin-1b, stimu-
lated only sphingomyelinases resulting in the accumulation of
ceramide (3). In rat renal mesangial cells, both tumor necrosis
factor a and nitric oxide donors have been shown to stimulate
sphingomyelinases, but only nitric oxide donors inhibited cer-
amidases and resulted in an increase in ceramide levels and
the consequent biological effects (4). Also, in smooth muscle
cells, oxidized low density lipoprotein has been shown to stim-
ulate sphingomyelinases, ceramidases, and sphingosine ki-
nase, leading to the production of sphingosine-1-phosphate,
which these authors suggested promotes the proliferation of
these cells (5). Ceramidases have also been shown to be acti-
vated in response to platelet-derived growth factor in rat glo-
merular mesangial cells (6). These studies underscore a key
role for ceramidases in regulating cell death and proliferation,
in response to various stimuli and in different cell types. How-
ever, to date, there has been a paucity of molecular tools to
study the function of ceramide and to understand the signifi-
cance of nonlysosomal enzymes of ceramide metabolism.
We recently purified a rat brain membrane-bound cerami-
dase with a pH optimum in the neutral to alkaline range (7). In
this study, we used peptides obtained from purified rat brain
enzyme to clone the human isoform. We also demonstrate using
a GFP-ceramidase construct that the enzyme is localized in mi-
tochondria. These results demonstrate significant compartmen-
tation of sphingolipid metabolism and raise important possibili-
ties on direct interaction between ceramide and mitochondria.
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EXPERIMENTAL PROCEDURES
Materials
Human kidney rapid amplification of cDNA ends (RACE) library,
human multitissue Northern blot, ExpressHyb solution, pEGFP-C3
vector, RACE DNA polymerase, and anti-GFP polyclonal antibody were
from CLONTECH. Taq DNA polymerase and T4 DNA ligase were from
Roche Molecular Biochemicals. The vector pcDNA3.1/HisC, TOPO TA
cloning kit, and Nick translation kit were from Invitrogen. KpnI and
ApaI restriction enzymes were from Promega. Polyvinylidene difluoride
membranes were from Applied Biosystems. Bradford protein assay and
gel electrophoresis apparatus were from Bio-Rad. Polyacrylamide gels
were from Novex. Superfect was from Qiagen. Mitotracker Red
CMXRos and tetramethylrhodamine methylester (TMRM) were from
Molecular Probes. a-32P was from Amersham Pharmacia Biotech.
[3H]C16-ceramide was synthesized as described (8). Peptide sequences
(1 and 2) were obtained at the microchemical facility at Emory Univer-
sity School of Medicine. Peptide (3) sequence and all DNA sequences
were obtained at the protein and DNA Sequencing facility of the Med-
ical University of South Carolina.
Methods
Peptide Sequences—Rat brain enzyme was purified as described (7).
Three preparations of 100–120 rat brains each were used. The purified
protein from the last column was subjected to SDS-polyacrylamide gel
electrophoresis, the gel was stained directly with Coomassie Blue or
transferred to polyvinylidene difluoride membrane using CAPS buffer,
pH 11, as transfer buffer, and the membrane was then stained. The
CDase band was excised from the gel or from the membrane and
subjected to digestion using AspN. The digest mixture was separated by
microcapillary reversed phase HPLC, and selected peptides were sub-
mitted to Edman degradation and sequencing.
Cloning of CDase—The sequences of the obtained peptides were used
to search the data base of the GenBankTM. The peptides identified a
putative slug protein (accession no. 2367392) and two human ESTs
(accession no. AA913512 and AC012131). The following primers were
synthesized: forward primer based on the EST AC012131, CTGAGTG-
GCACTCACACTCATTCAGGT; and the reverse primer based on the
EST AA913512, GGCTTCAGAATGTCCTGCTTCCGA. PCR amplifica-
tion was performed using the human kidney RACE library as a tem-
plate. A 1.8-kb fragment was obtained. New primers were then desig-
nated on the 59- (reverse, ACCTGAATGAGTGTGAGTGCCACTCAG)
and 39- (forward, TTCGGGGATGTCCTGCAGCCAGCAAAACCTGAA-
TACAG) ends of the 1.8-kb fragment to perform touch down PCR. After
two RACE rounds, a 59-end fragment of 0.7 kb and a 39-end fragment of
0.6 kb were obtained. Assembling the 1.8-kb fragment and the 59- and
39-ends fragments resulted in a fragment of around 2.5 kb, with a
putative open reading frame of 2289 base pairs.
Construction of Full-length CDase Vectors—The full-length CDase
fragment was generated by PCR using the forward primer ATGAGT-
GCCATCACAGTGGCCCTTCTC starting at the longest start codon and
the reverse primer ACTAAATAGTTACAACTTCAAAAGCCGGG. The
forward primer also contained the KpnI site sequence, and the reverse
primer contained the ApaI site sequence. PCR amplification was per-
formed at a denaturing temperature of 94 °C for 1 min followed by
annealing at 65 °C for 2.5 min and extension at 72 °C for a total of 35
cycles. The amplified fragment (2289 base pairs) was separated by
electrophoresis on 1.5% agarose gel. After purification, the full-length
cDNA was subcloned into TOPO blunt end cloning vector. Sequencing,
using T7 and M13 reverse primers of the TOPO inserts, revealed
multiple full-length clones in the sense and in the antisense direction.
The sense fragments were named TOPO-CDase and were used to
construct the pcDNA3.1/HisC-CDase vector. To this end, TOPO-CDase
vector was digested with KpnI and ApaI overnight. The resulting frag-
ment was gel-isolated and subcloned into the same sites in pcDNA3.1/
HisC vector, the His-tag being at the N terminus of ceramidase.
To construct pEGFPC3-CDase vector, the open reading frame of
CDase cDNA was first amplified as described above. The amplified
product was then digested by restriction enzymes KpnI and ApaI and
cloned into KpnI and ApaI sites of the vector pEGFPC3, thus generat-
ing a GFP tag at the N terminus of ceramidase protein. The sequence
and orientation of the fragments were then confirmed by sequencing.
Northern Blot Analysis—Pre-made commercial Northern blot and
hybridization solution were used in this experiment. The human EST
AA913512 fragment (0.67 kb) was labeled by Nick translation using
[32P]dCTP. The labeled fragment was used to probe a human multitis-
sue Northern blot as described (9). Each lane on the blot contained 2 mg
of poly(A)1 RNA. The membrane was first prehybridized overnight at
65 °C in ExpressHyb solution. The radioactive probe was then denatur-
ated by boiling for 2 min and added to the blot in ExpressHyb solution.
Hybridization was carried out overnight at 65 °C. After washing, the
blot was exposed to x-ray film for 5 days at 280 °C.
Transfection—HEK 293 cells and MCF-7 cells were seeded at 105
cells/dish. Transfection with vector alone (pcDNA3.1/HisC) or vector
containing full-length CDase (pcDNA3.1/HisC-CDase) was performed
using Superfect and 3 mg of each plasmid/dish. After 3–4 h of incubation
with the mixture, the cells were washed with phosphate-buffered saline
and fresh medium was added. After 48 h, CDase activity was measured.
Protein Assay and SDS-Polyacrylamide Gel Electrophoresis—Protein
concentration was determined using the Bradford assay. SDS-poly-
acrylamide electrophoresis was performed according to Laemmli (10).
Western Blot—Cells were scraped in 1 ml of lysis buffer (50 mM Tris,
pH 7.4, 5 mM EDTA, 1% Triton X-100, 300 mM NaCl, 1 mM phenylmeth-
ylsulfonyl fluoride, and 2 mg/ml of leupeptin and aprotinin) and kept on
ice for 10–15 min. To remove insoluble material, lysates were centri-
fuged at 12,000 3 g for 15 min. Samples (10 mg of lysates) were then
boiled for 5 min, loaded onto a 7.5% SDS-polyacrylamide gel, electro-
phoresed, and transferred to a nitrocellulose membrane. The GFP-
CDase fusion protein was detected by using anti-GFP affinity purified
antibody at a dilution of 1:1000 and a anti-rabbit secondary antibody at
a dilution of 1:3000.
Immunoprecipitation—For immunoprecipitation, cell lysates were
first precleared by incubating with 30 ml of a mixture of protein A/pro-
tein G agarose beads for 30 min followed by centrifugation at 12,000 3
g for 1 min. The cleared lysates were then rocked in the presence of 5 mg
of anti-GFP antibody or 5 mg of control IgG complexed to a mixture of
protein A/protein G agarose. After 2 h of incubation, the beads were
centrifuged at 12,000 3 g for 10 s, washed twice with 0.5 ml of lysis
buffer without protease inhibitors and with only 0.1% Triton X-100
(wash buffer). All steps were carried out at 4 °C. Beads were finally
resuspended in wash buffer, and ceramidase activity was measured.
Ceramidase Activity—CDase activity was measured as described in
Ref. 7, using [3H]C16-ceramide as substrate in a mixed micelle assay
system.
Microscopy—Cells were plated on 35-mm diameter glass coverslips.
They were transfected with 1 mg of empty vector or vector-containing
ceramidase as described above. After 48 h, the cells were loaded with 25
nM Mitotracker Red for 20 min and then washed with phosphate-
buffered saline and fixed. For confocal microscopy, images were col-
lected by Zeiss 410 LSCM system equipped with krypton/Argon laser
and a 60 X oil merge lens (N.A 1.4). After 48 h of transfection, cells
plated on glass coverslips were mounted on a microscopy stage and
maintained in phosphate-buffered saline buffer. GFP images were col-
lected by excitation at 488 nm and emission at 516–560 nm. To label
mitochondria, cells were subsequently co-loaded with 50 nM TMRM.
The TMRM images were then taken by excitation at 568 nm and
emission at 590 nm long-path emission filter. To void fluorescent cross-
talking, green GFP and red TMRM fluorescence were taken
sequentially.
RESULTS
Sequencing and Cloning of CDase—We have purified to ho-
mogeneity a rat brain CDase with a pH optimum in the neutral
to alkaline range (7). The scale up of the purification protocol
was optimized to obtain high amounts of the protein. In each
preparation (100–120 rat brains), 1–10 mg of CDase protein
were obtained (visible by Coomassie Blue). After digestion and
HPLC separation of the AspN digest, three peptide sequences
of 14–17 amino acids (Table I) were obtained. The data base of
TABLE I
Alignment of the sequenced rat brain peptides to the
human cloned protein
The peptide sequences obtained from the purified rat brain enzyme
were aligned to the peptide sequences deduced from the cloned mito-









the GenBankTM was searched using peptides 1 and 2, and the
same human EST sequence (accession no. AA913512) was iden-
tified by both peptides. We then searched using the human
EST and all three peptides and identified a putative slug pro-
tein (accession no. 2367392). The human EST aligned at the C
terminus of the slug protein. Next, the slug protein was used to
search the GenBankTM Data base, and this yielded a human
genomic sequence of 15,960 kb (accession no. AC012131), which
aligned with a region close to the N terminus of the slug
protein. Thus, by performing this search and based on the slug
putative protein sequence, human nucleotide sequences were
obtained that were localized close to the N and C terminus of
the human protein. Based on these observations, a forward
primer from this human genomic sequence (no. AC012131) and
a reverse primer from the human EST (no. AA913512) se-
quence were designed, and PCR was performed using a human
kidney library as template. Gel analysis of the PCR reaction
showed that a 1.8-kb fragment was amplified, in close agree-
ment to what was expected based on the slug sequence. We
isolated, subcloned, and sequenced this fragment and found
that it contains the human EST (accession no. AA913512),
indicating that this 1.8-kb fragment corresponds to part of the
human CDase sequence.
New primers of both ends of the 1.8-kb human fragment
were synthesized, and RACE-PCR was performed using a hu-
man kidney RACE library as template. After two rounds of
PCR, a 59-end fragment of 0.7 kb and a 39-end fragment of 0.6
kb were obtained. These fragments were then gel-isolated,
subcloned into TOPO vector, and sequenced. The fragments
contained the primer sequences, part of the 1.8 kb-fragment,
and did not identify any EST in the GenBankTM of known
function, indicating that these fragments most probably corre-
spond to the extension of the 59-end and the 39-end of the 1.8-kb
human fragment.
The 59-end fragment contained multiple start ATG codons in
frame, and the 39-end contained two stop codons next to each
other. Taking the first ATG (longest) as start codon and the
double stop codon at the 39-end as stop codon, an open reading
frame of 2289 base pairs encoding a protein of 84 kDa was
predicted.
Primers of both ends, starting at the predicted start and stop
codons were made and used to amplify the full-length CDase
cDNA from the human kidney library. The full-length CDase
cDNA was finally subcloned into pcDNA3.1/HisC and
pEGFP-C3 mammalian expression vectors, and the correct se-
quence and orientation were identified by sequencing. The
full-length CDase sequence and the predicted amino acid se-
quence are shown in Fig. 1. Fig. 1 also shows the position of the
sequenced peptides obtained from rat brain, and Table I pre-
sents their identity to the cloned human enzyme.
Analysis of the protein sequence using the SMART program
revealed one transmembrane domain between amino acids 505
and 525 (Fig. 1) and three other putative transmembrane do-
mains (amino acids 176–196, 313–333, 431–451, and 543–563).
The sequence also revealed the presence of a signal peptide
(amino acids 1–19) and a region of low compositional complex-
ity (amino acids 38–66). This region of low complexity showed
some futures of a mitochondrial targeting sequence, it was rich
in amino acids serine and alanine, contained two positively
charged amino acids (arginine and histidine), and did not con-
tain acidic residues (11). Further analysis using the program
PSORT at the Expasy Molecular Biology server showed that at
a probability of 66% this peptide sequence would localize in
mitochondria. Also, we identified a putative myristoylation site
(Fig. 1), several putative phosphorylation sites (protein kinase
C, cAMP-dependent protein kinase, and casein kinase 2) and
putative N-glycosylation sites (not shown).
The CDase amino acid sequence showed no similarity to any
FIG. 1. cDNA and deduced amino acid sequences of human ceramidase. The first and second columns indicate the nucleotide and the
deduced amino acid sequences, respectively. Nucleotide and amino acid positions are shown on the right. Position amino acid 1 refers to the first
nucleotide and amino acid of the ceramidase-predicted coding region. Amino acid sequences determined by Edman sequencing of the purified rat
brain enzyme (see Table I) are underlined. The putative signal peptide (double underline), myristoylation site (boxed), low complexity signal
(- - -), and transmembrane domain (—) are also shown.
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known mammalian protein. The protein was homologous to
three putative proteins from Arabidospis thaliana (accession
no. AAD32770), Mycobacterium tuberculosis (accession no.
CAB09388), and Dictyostelium discoideum (accession no.
2367392) (Fig. 2), indicating that these proteins may be cer-
amidases in those organisms. There were several blocks highly
conserved in all of these proteins, and the overall homology
between the human and those proteins ranged between 30 and
50%.
Northern Blot Analysis—To determine tissue distribution of
this ceramidase, we performed Northern blot analysis using
the 39-end of CDase cDNA (0.67 kb) as a probe and a human
premade multitissue Northern blot. Fig. 3 shows the presence
of a minor high size band at around 7 kb, a major band of 3.5
kb, and two other minor bands of 3.1 and 2.4 kb. The presence
of multiple bands could be the result of alternative splicing.
The major 3.5-kb ceramidase band was ubiquitously expressed
in all tissue represented on the blot, with the highest expres-
sion in kidney, skeletal muscle, and heart.
Overexpression and Characterization of CDase—HEK 293
cells and MCF7 cells were transfected with empty vector
(pcDNA3.1/HisC) or vector containing the full-length CDase
(pcDNA3.1/HisC-CDase). Cells were then harvested, and cer-
amidase activity was measured on the lysates. As shown in Fig.
4A, overexpression of CDase in these cells increased CDase
activity (at pH 9.5) 50-fold in HEK 293 cells and 12-fold in
MCF7 cells as compared with control empty vector-transfected
cells.
To ascertain that the cloned cDNA encodes ceramidase pro-
tein, we constructed a GFP-tagged ceramidase, in which the
GFP was at the N terminus of ceramidase protein. We then
transfected 293 cells with this construct and performed West-
ern blot and immunoprecipitation experiments using GFP an-
tibody. As shown in Fig. 4B, cells overexpressing the fusion
protein contain a GFP-positive band at around 123 kDa, this
band being absent in control cells transfected with the pEG-
FPC3 empty vector. Based on GFP molecular mass (27 kDa),
CDase molecular mass was deduced to be around 96 kDa. This
was in agreement with 90 kDa mass on SDS-polyacrylamide
gel electrophoresis of the rat brain purified enzyme. Further,
immunoprecipitation of the fusion protein with anti-GFP anti-
body increased CDase specific activity by 8-fold in the immu-
noprecipitant, whereas control rabbit IgG failed to immunopre-
cipitate any activity. All together, these results clearly indicate
that the cloned full-length cDNA encodes the CDase protein.
Next, we compared the properties of this human enzyme to
the rat brain enzyme. To this end, 293 cells were transfected
with the pcDNA3.1/HisC-CDase construct, and characteriza-
tion experiments were performed using lysates of these over-
expressing cells. Fig. 4C shows the pH profile of the human
CDase. The enzyme catalyzed the hydrolysis of ceramide in a
relatively broad range with a pH optimum between pH 7.5 and
9.5. We also tested the effect of EDTA, MgCl2, and CaCl2 (all at
10 mM) and found that they did not affect significantly cerami-
dase activity. Dithiothreitol at 20 mM was found to inhibit the
FIG. 2. Sequence comparison of human ceramidase to putative ceramidases from A. thaliana, M. tuberculosis, and D. discoideum.
Identical amino acids in all four proteins are shaded. Boxed areas indicate gaps introduced to optimize the alignment. Alignment was performed
using the MacVector, Multiple sequence Alignment program.
FIG. 3. Northern blot analysis of poly(A)1 RNAs from human
tissues. The labeled 39-end of human ceramidase was used to probe a
human multiple tissue Northern blot; each lane contained 2 mg of
poly(A)1 RNA. Size markers are indicated on the right. The major
ceramidase band corresponds to a size of 3.5 kb.
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activity by 75% (Fig. 4D). Finally, the predicted isoelectric
point value was 6.69. All these properties are in close agree-
ment with the purified rat brain enzyme.
Localization of Ceramidase—Our previous results of tissue
subfractionation,2 together with the putative mitochondrial
targeting sequence suggested the possible localization of this
ceramidase in mitochondria. To assess this hypothesis, we
transfected MCF7 and HEK 293 cells with the GFP-tagged
ceramidase construct. After transfection, cells were stained
with Mitotracker Red, a specific mitochondrial probe. In MCF7
and HEK 293 cells, the GFP control signal (empty vector) was
diffuse in all compartments (not shown) whereas the GFP-
ceramidase signal colocalized with the red mitochondrial probe
(Fig. 5A). To further confirm these observations, we performed
similar experiments using confocal microscopy. Results in
MCF7 and HEK 293 pEGFPC3-Cdase-transfected cells showed
a punctuate mitochondrial pattern of the GFP-ceramidase sig-
nal (Fig. 5B). The addition of a TMRM mitochondrial probe
showed that the ceramidase fusion protein signal colocalizes
again with this mitochondrial probe (Fig. 5B), clearly demon-
strating that this ceramidase is localized in mitochondria.
DISCUSSION
We have cloned and characterized the first mammalian mi-
tochondrial ceramidase. The enzyme has characteristics simi-
lar to the rat brain purified enzyme in its estimated molecular
mass, isoelectric point, optimum pH, and dependence on cat-
ions (7). Protein sequence analysis showed the enzyme is con-
served in bacteria, plant, and mammals. While we were pre-
paring this manuscript, Okino et al. (12) published the cloning
of an alkaline ceramidase from Pseudomonas aeruginosa (ac-
cession no. 6594292), and Tani et al. (13) published the purifi-
cation of the same protein from mouse liver. The sequence of
this protein was also homologous to the M. tuberculosis Gen-
BankTM putative protein. These observations indicate that our
human clone and the P. aeruginosa clone encode the same
enzyme.
2 S. El Bawab and Y. A. Hannun, unpublished results.
FIG. 4. Overexpression and characterization of CDase. A, HEK
293 and MCF7 cells were transfected with vector alone (pcDNA3.1/
HisC) or vector containing CDase cDNA (pcDNA3.1/HisC-CDase). 48 h
after transfection, CDase activity was measured as described under
“Experimental Procedures.” Data are the mean of three experiments. B,
cells transfected with empty vector (pEGFPC3, control) or vector con-
taining CDase (pEGFPC3-CDase, Overexpression) were lysed, and
CDase activity was measured on cell lysates. A fraction of the overex-
pressing cell lysate was also immunoprecipitated with anti-GFP anti-
body or with normal rabbit IgG as a control. Immune complexes were
precipitated by the addition of a mixture protein A/protein G agarose.
Ceramidase activity was measured on lysates and immunoprecipitant
(IP). The inset shows a Western blot using GFP antibody of control and
overexpressing cells. Ab, antibody. C and D, the activity of CDase was
measured in cells transfected with pcDNA3.1/HisC-CDase vector. C,
the pH was adjusted by the addition of the following buffers at a final
concentration of 100 mM: acetate (pH 4 and 5), phosphate (pH 6 and
6.5), Hepes (pH 7–8), glycine (pH 9–10.5). D, cations and EDTA were
used at 10 mM, and dithiothreitol (DTT) was used at 20 mM.
FIG. 5. Localization of ceramidase. Cells were transfected with 1 mg of pEGFPC3 empty vector (results not shown) or pEGFPC3-CDase vector
containing ceramidase. After 48 h they were stained with specific mitochondrial probes, washed, and then fixed before microscopy observation. A,
cells were stained with Mitotracker Red and visualized by fluorescence microscopy. B, cells were stained with TMRM and visualized by confocal
microscopy.
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In addition, recently Mao et al. (14) reported the cloning of an
alkaline ceramidase from the yeast Saccharomyces cerevisiae.
Two lines of evidence suggest that this yeast enzyme is differ-
ent from the human mitochondrial ceramidase. First, amino
acid comparison showed no homology between the two proteins.
Second, the yeast enzyme failed to hydrolyze C16-ceramide but
rather uses phytoceramide preferentially as a substrate. Fur-
ther, the whole genome of S. cerevisiae has been reported. Very
interestingly we could not find any protein or DNA sequence
from S. cerevisiae homologous to the human, slug, or mycobac-
terium ceramidase.
It is very intriguing that lower organisms such as M. tuber-
culosis and P. aeruginosa harbor the mitochondrial cerami-
dase-specific gene in their genome, whereas the eukaryotic
genome of S. cerevisiae does not. It would be interesting to
determine if this is related to the pathogenicity of P. aeruginosa
and M. tuberculosis. It is also intriguing to know whether the
yeast ceramidase gene is also found in other organisms. At
present, the answer to these questions is not clear.
On the other hand, in their reports, Mao et al. (14) and Tani
et al. (13) have shown that the yeast ceramidase and the
purified mouse ceramidase can also catalyze the reverse reac-
tion by condensing phytosphingosine or sphingosine and a free
fatty acid into phytoceramide or ceramide. Both enzymes failed
to use fatty acyl-CoA as substrate. Using purified rat brain
enzyme we also found that the purified enzyme catalyzes the
synthesis of ceramide through a CoA-independent mecha-
nism.3 These observations raise the important question of the
physiological function of these enzymes in cells and their role in
ceramide metabolism.
Finally, we present evidence indicating that the human en-
zyme localizes in mitochondria. This nearly exclusive presence
of this ceramidase in mitochondria suggests the existence of a
specific pool of ceramide in mitochondria. Given the emerging
significance of both mitochondria (15) and sphingolipid metab-
olism (1, 2) in the regulation of stress and apoptosis, this
localization of ceramidase to mitochondria raises possibilities
of a specific function of mitochondrial sphingolipids in cell
regulation.
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